Llwytho...

A Phase III Study of IncobotulinumtoxinA in the Treatment of Glabellar Frown Lines

Objective: To investigate the efficacy and safety of incobotulinumtoxinA (also known as botulinum toxin type A [150 kDa], free from complexing proteins, or previously as NT 201), for the treatment of glabellar frown lines, in a prospective, open-label, multicenter, Phase III trial. Design: The study...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Imhof, Matthias, Kühne, Ulrich
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Matrix Medical Communications 2011
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3196303/
https://ncbi.nlm.nih.gov/pubmed/22010053
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!